Surgery Plus Chemo Versus Chemoradiotherapy Followed by Surgery Plus Chemo for Locally Recurrent Rectal Cancer

Surgery Plus Chemo Versus Chemoradiotherapy Followed by Surgery Plus Chemo for Locally Recurrent Rectal Cancer is a phase 3, randomised interventional study registered as NCT04288999 by National Cancer Center Hospital East, with a registry enrolment figure of 110 participants, started 2019-10-01 and due to reach its primary completion in 2025-08. Interventions recorded: Chemotherapy; Preoperative radiotherapy; Procedure. Conditions listed: Rectal Cancer Recurrent. Primary outcome: Locally recurrent free survival. Colorectal eligibility wording from the registry: "Histopathologically proven adenocarcinoma or adenosquamous carcinoma on the resected specimen of the initial rectal cancer or endoscopic biopsy from the initial rectal cancer". Sites: Japan. No results are recorded here; the registry entry is the source.